TABLE 1.

Characteristics of the B. henselae isolates studied

Isolate	Position in the geld	Source	No. of CFU/ml of blood	Growth time (days)	Reference or source
Houston-1a	C	HIVb			11
FR96/BK3	D	Cat	200	10	15
FR96/BK8	E	Cat	120	12	15
FR96/BK26II	F	Cat	30	6	15
FR96/BK36	G	Cat	100	7	15
FR96/BK36II	H	Cat	100	8	15
FR96/BK38	I	Cat	600	6	15
FR96/BK74	K	Cat	200	6	15
FR96/BK75	L	Cat	120	8	15
FR96/BK75II	M	Cat	100	8	15
FR96/BK77	N	Cat	400	7	15
FR96/BK78	O	Cat	240	7	15
FR96/BK79	P	Cat	800	7	15
FR96/K2	Q	Cat (CSD)c	400	10	This study
FR96/K4	R	Cat (CSD)	1,200	6	This study
FR96/K5	S	Cat (CSD)	2,000	6	This study
FR96/K6	T	Cat (CSD)	4,000	7	This study
FR97/K7	U	Cat (CSD)	10,000	10	This study

^aHouston-1 = ATCC 94793 = CIP 103737. 

^bHIV, patient infected with human immunodeficiency virus. 

^cCat (CSD), cat to which patient with CSD was exposed. 

^dLetters correspond to lanes in Fig. 1 to 6.